Application of microfluidics in cancer diagnosis and treatment

Bader Kharaibet, Edward Weaver, Dimitrios A. Lamprou*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)peer-review

Abstract

Cancer is one of the leading causes of mortality globally, with a possibility to prevent many of these incidents via enhancing lifestyle habits and early detection through screening for better interventional outcomes. Current conventional analytical methods lack specificity and sensitivity, also requiring invasive methods to obtain samples. Thus, with the advancement in health-related technologies, microfluidic (MF)-based technology provides a reliable opportunity in early detection, isolation and separation of cancer cells and biomarkers without sacrificing sensitivity and specify. Also, it can be used for new drug development and screening. The MF devices are fast, cheap, and with future options to be integrated with next generations technologies such as artificial intelligence.

Original languageEnglish
Title of host publicationMicrofluidics in pharmaceutical sciences: formulation, drug delivery, screening, and diagnostics
EditorsDimitrios A. Lamprou, Edward Weaver
PublisherSpringer Cham
Chapter11
Pages267-291
ISBN (Electronic)9783031607172
ISBN (Print)9783031607165, 9783031607196
DOIs
Publication statusPublished - 22 Jun 2024

Publication series

NameAAPS Introductions in the Pharmaceutical Sciences
Volume14
ISSN (Print)2522-834X
ISSN (Electronic)2522-8358

Keywords

  • Metastasis
  • Biomarkers
  • organ-on-chips
  • Cancer
  • Microfluidics
  • Drug Screening

Fingerprint

Dive into the research topics of 'Application of microfluidics in cancer diagnosis and treatment'. Together they form a unique fingerprint.

Cite this